This football season, Teva is increasing education around tardive dyskinesia (TD) by launching 'The Other TD' campaignTD is a chronic movement disorder impacting one in four people who take certain pr ...

This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD’ campaignTD is a ...

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of ...

The FDA announced that Teva Pharmaceuticals USA and Amerisource Health Services issued voluntary recalls for blood pressure ...

The FDA says drugmakers have recalled more than a half-million bottles of the blood pressure medication over concerns it may ...

Neither Teva nor the FDA issued guidance on what to do with the recalled tablets. But according to GoodRx, anyone affected by a drug recall is advised to check their medication's lot number, contact ...

Jefferies London Healthcare Conference Tuesday, November 18, 2025, at 11:00 A.M. Greenwich Mean Time (6:00 A.M. ET) To access a live webcast of the presentation, visit Teva’s Investor Relations ...

Harel Insurance Investments & Financial Services Ltd. increased its Teva holding to 6.84% of its reportable U.S. equity ...

Teva Pharmaceuticals has agreed to pay $35 million to resolve a major antitrust lawsuit alleging that the company ...

Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR asthma inhalers, ...

Teva Pharmaceutical Industries Ltd. will pay $35 million to settle claims it delayed generic competition in the asthma inhaler market.